The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 Aug 2023 16:49

RNS Number : 5191K
Iconic Labs PLC
25 August 2023
 

 

25 August 2023

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

 

Result of AGM

 

Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's Annual General Meeting ('AGM') held at 3pm today, all resolutions were duly passed by way of poll.

At the meeting, inter alia, a resolution was passed which approved the consolidation of the Company's ordinary shares on a 10,000 for 1 basis, such that every 10,000 ordinary shares of £0.00001 each were consolidated into 1 ordinary share of £0.1 in nominal value.

As a result, the Company's existing issued share capital of 46,996,580,000 ordinary shares of £0.00001 was consolidated into 4,699,658 ordinary shares of £0.1, each with one voting right. Admission in respect of such new ordinary shares will become effective and that dealings in those new ordinary shares will commence on 30 August 2023. As a result of the consolidation, the ISIN of the ordinary shares will change from GB00BD060S65 to GB00BRBJ3P08.

The above figure of 4,699,658 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The results of the poll were as follows: 

 

Resolutions

For

%

Against

%

Withheld

1

To receive and adopt the accounts for the financial year ended 30 June 2021.

6,029,829,160

99.02

59,851,506

0.98

89,879,728

2

To receive and adopt the accounts for the financial year ended 30 June 2022.

6,029,829,160

99.02

59,851,506

0.98

89,879,728

3

To re-appoint Norden Audit Limited as Auditors.

6,021,542,347

98.66

81,671,752

1.34

76,346,295

4

To authorise the Directors to determine the remuneration of the Auditors.

6,000,845,301

98.32

102,368,798

1.68

76,346,295

5

To re-appoint Bradley Tyler Taylor as a Director.

6,024,039,929

98.76

75,405,149

1.24

80,115,316

6

To re-appoint David Štýbr as a Director.

6,014,911,904

98.61

84,533,174

1.39

80,115,316

7

To re-appoint Marija Hrebac as a Director.

6,004,365,470

98.44

95,079,608

1.56

80,115,316

8

To re-appoint Emmanuel Blouin as a Director.

5,994,271,904

98.28

105,173,174

1.72

80,115,316

9

Issued ordinary share capital be consolidated and divided into 4,699,658 ordinary shares of £0.1 each.

5,910,559,957

96.84

192,654,142

3.16

76,346,295

10

To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £1,905,217.39.

6,012,800,530

98.52

90,413,569

1.48

76,346,295

Special Resolutions:

11

To empower the Directors to generally allot relevant equity securities under Resolution 10.

6,010,800,530

98.49

92,413,569

1.50

76,346,295

12

To authorise the Directors to make market purchases of own shares.

6,039,251,219

98.95

63,962,880

1.04

76,346,295

 

A vote withheld is not a vote in law and is not counted in the calculation of the percentage of shares voted for or against any resolution.

 

- Ends -

 

For more information, please contact:

Iconic Labs

 

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPPUMCRUPWGAA
Date   Source Headline
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20238:04 amRNSConversion of Securities & Resignation of Director
27th Jan 202311:05 amRNSSecond Price Monitoring Extn
27th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 202312:08 pmRNSRestoration of Trading
25th Jan 20239:00 amRNSPrice Monitoring Extension
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
24th Jan 202312:00 pmRNSRestoration - Iconic Labs Plc
16th Jan 20235:24 pmRNSUpdate Regarding Sting Industries Acquisition
16th Jan 20237:00 amRNSIPEM
6th Jan 20238:10 amRNSCorporate Update
3rd Jan 20234:48 pmRNSAnnual Financial Report 2022
29th Dec 20223:58 pmRNSFinal Results 2021
22nd Dec 20229:02 amRNSFinancing Facility
16th Dec 20227:00 amRNSRegulatory Approval
14th Dec 20226:31 pmRNSDirectorate Change
30th Nov 202211:15 amRNSConversion of Securities
1st Nov 20224:50 pmRNSSubscription of convertible notes
22nd Sep 20225:59 pmRNSResults of Creditors and General Meetings
30th Aug 20226:19 pmRNSSettlement and CVA
23rd Aug 20224:57 pmRNSRetraction of claims
8th Jun 20226:05 pmRNSAdministration & proposed CVA update
8th Dec 20216:21 pmRNSResults of General Meeting
26th Nov 202110:05 amRNSAdjournment to the GM
19th Nov 202111:25 amRNSAdjournment to the GM - Replacement
18th Nov 20214:00 pmRNSAdjournment to the GM
15th Nov 20214:54 pmRNSAdjournment of General Meeting
7th Oct 202110:33 amRNSGeneral Meeting – Further adjournment
25th Aug 20212:44 pmRNSNOTICE OF APPROVAL OF ADMINISTRATORS' PROPOSALS
12th Aug 20211:22 pmRNSGM update and adjournment notice
13th Jul 20216:38 pmRNSGM update and adjournment notice
1st Jul 20214:48 pmRNSGM update and adjournment notice
16th Jun 20214:56 pmRNSAnnouncement of resignation of directorship
15th Jun 20214:27 pmRNSUpdate on General Meeting
7th Jun 20217:30 amRNSSuspension - Iconic Labs Plc
4th Jun 20216:39 pmRNSAppointment of Administrators
1st Jun 20219:05 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
26th May 20214:55 pmRNSDirectorate Change
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
24th May 202111:05 amRNSSecond Price Monitoring Extn
24th May 202111:00 amRNSPrice Monitoring Extension
24th May 20219:36 amRNSDirectorate Change
24th May 20219:05 amRNSSecond Price Monitoring Extn
24th May 20219:00 amRNSPrice Monitoring Extension
21st May 20217:00 amRNSNotice of GM
20th May 202111:05 amRNSSecond Price Monitoring Extn
20th May 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.